STAT1 GOF mutations with CMC were first described in 2001 and 2011, respectively; later, studies confirmed that STAT1-GOF mutations cause immunodeficiency and immune dysregulation, with a wide clinical spectrum [54]. This evidence concerns the gene STAT1 and Immunodeficiency.